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Abstract
Background: Multi-factorial etiology exists in pathophysiology of neurodegenerative diseases. The imbalance of
anti-oxidant enzymes and dopamine level leads to Parkinsonism. The objective of this study was to assess the
protective effect of Spirulina fusiform alone and in combination with amantadine against Parkinsonism effect in
6-hydroxydopamine (6-OHDA) induced rat model.
Methods: S. fusiform was administered in different groups (500 mg/kg, once daily and twice daily) and a
combination of spirulina (500 mg/kg, once daily) with amantadine (20 mg/kg once daily) for 30 days before and
14 days after a single injection of 6-OHDA into the dorsal striatum. Post lesion produced rotational behavior which
was measured at two week intervals (37th and 44th day). Locomotors activity was also done at 44th and muscle
coordination at 48th day. Dorsal striatum was isolated from rat brain for evaluating the antioxidant assays and
dopamine content at 49th day.
Results: Both the body rotations (ipsilateral and contralateral) were found to have a statistically significant (p < 0.001)
decrease by 34.26 and 52 % after treatment with spirulina (Twice a day) in spirulina treated lesioned group. A higher
percentage of improvement was shown in the reduction of ipsilateral (57.34 %) and contralateral (78.3 %) rotations in
combination of spirulina with amantadine treated lesioned group rather than spirulina alone treated lesioned groups
when compared with positive control lesioned group. Body movements and locomotor activity were improved
statistically (p < 0.0001) significant in both treated lesioned groups (Combination of spirulina with amantadine and
spirulina twice daily). Similar results were also seen in anti-oxidant levels which later on reached to the normal value.
The levels of dopamine content had a statistically significant (p < 0.0001) increase by 78.3 % only in case of spirulina
with amantadine treated lesioned group.
Conclusion: Spirulina is a potent nutraceutical supplement all over the world, so my preclinical study may contribute
to give an additional adjuvant drug therapy in aging related disorders (Neurodegenerative as well as diabetes
associated neurodegenerative disorders).
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Background
Neurodegenerative disorders encompass a condition
where nerve cells of different parts of brain and spinal
cord vanish leading to either functional loss or sensory
dysfunction [1]. Parkinson’s disease (PD) is second most
prevalent neurological disorder that is characterized by
progressive neurodegeneration affecting dopaminergic
neurons in the negrostriatal pathway [2]. The most
common symptoms of Parkinsonism are akinesia, bra-
dykinesia, rigidity, tremor and postural abnormalities
[3, 4]. Some of the common causes which are respon-
sible for etiology of this disorder include oxidative
stress, mitochondrial damage, protein dysfunctions,
and inflammation [1]. Pathologically, Parkinson’s dis-
ease is characterized by the significant degeneration of
dopaminergic neurons in the substantia nigra pars
compacta, which leads to the depletion of dopamine in
its striatal projections and other brain stem neurons,
with consequent disruption of the cerebral neuronal
systems responsible for motor functions. Despite of major
advances in the current understanding of Parkinsonism
pathology, the exact mechanism involved in this neuro-
degenerative cascade remains unclear. However, many
studies claim that excessive generation of reactive oxy-
gen species (ROS) and inflammation may play a central
role in the neuropathology of PD [5].
Some of the studies suggest the use of nutraceuticals
as natural antioxidants as an appropriate strategy to di-
minish the progression of neurodegenerative diseases
[6]. The nutraceuticals can be given as an adjuvant
therapy to fabricate synergistic/additive effects and to
reduce the dose of drug.
Spirulina (Spirulina fusiform), a type of blue green
algae, is a cyanobacterium belonging to the Oscillatora-
ceae family. It is gaining more attention by medical sci-
entists as a nutraceutical and as a source of potential
pharmaceutical. It has been consumed as primary food
source by Aztecs and Mayans since thousands of years.
Recently, we also reported the positive interaction
between spirulina and glitazone to prevent diabetic
osteoporosis [7–9]. Several studies revealed the poten-
tial properties of spirulina include anti-carcinogenic,
immunostimulants, antigenotoxic, anti-hepatotoxic,
anti-inflammatory, anti-diabetic and anti-hypertensive.
Spirulina is also well known as anti-oxidant nutraceut-
ical [10] as it contains high levels of antioxidant and
anti-inflammatory molecules such as c-phycocyanin,
one of the richest sources of plant proteins (60–70 %),
vitamins especially vitamin B12 and provitamin A (β-
carotene), γ-linolenic acid, phenolic compounds and
minerals like calcium, chromium and magnesium [11, 12].
Another species, Spirulina platensis extract attributed
protective response on birds, aquatic and animal’s species
against oxidative stress. Studies have shown that chronic
treatment of spirulina demonstrated a potent free radical
scavenging activity on Oreochromis niloticus [13] and
albino wistar rats after exposed to deltamethrin intoxi-
cation [14]. The protective effect of spirulina against
hepatotoxicity caused by erythromycin thiocyanante
induced oxidative damage on Egyptian baladi bucks
reported by another researcher [15]. Spirulina shows
significant immunodulatory effect in acetic induced
colitis in experimental rats [16].
Number of studies has shown spirulina to exert pro-
tective effect in the treatment of neurodegenerative
disorders (Parkinsonism and Alzheimer disorder).
Stromberg study also suggests a protective response by
enhancement in the recovery of striatal dopamine tyro-
sine hydroxylase (TH) positive fibers and TH positive
neurons in the substantia nigra pars compacta in ex-
perimental rat induced Parkinsonism after feeding with
spirulina [17]. Spirulina exerts a significant protective
effect on hippocampus neural progenitor cells against
lipopolysaccharide induced acute systemic inflamma-
tory [18]. Anti-inflammatory and antioxidant effect
of spirulina demonstrate a neuroprotectivity against
adeno-associated virus vector (AAV9) in substantia
nigra of rats reported by Prabon [19]. Amantadine is
an antiviral drug that is also used in the treatment of
PD. Basically; it is a synthetic compound which can be
used in advanced stage of Parkinsonism and motor
fluctuations. However, this drug has a very fewer side
effects other than anti Parkinsonism drugs. So, it can
be used at low doses for chronic treatment [20].
Though, many literatures suggest that spirulina is a
strong supplementation food and reported as anti-
oxidant compound for the prevention of Parkinsonism
but it could be used in combination with amantadine
for the pretreatment of Parkinsonism on rats. Hence,
the present study was undertaken to assess the neuro-
protectivity of spirulina alone and in combination with
amantadine in experimental rat induced Parkinsonism.
Methods
Drugs and chemicals
6-hydroxy dopamine hydrochloride (6-OHDA HCL),
amantadine, apomorphine hydrochloride, thiobarbituric
acid (TBA) and ascorbic acid were purchased from
Sigma Aldrich lab ltd, (Foreign Holding Chemical Com-
pany, Bangalore, India). All other reagents and chemicals
used in the study were of HPLC analytical grade. Spirulina
fusiformis in the form of powder was a gift from RECON
Ltd., (Bangalore, India).
Animals
Adult male wistar albino rats were supplied by National
Institute of Pharmaceutical Education Research, (Mohali),
Punjab. At the beginning of the study, the rats aged were
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7–8 weeks old and weighed about 180–200 g. Before the
surgical procedures, the rats were housed in stainless steel
cages and kept on a 12 h light/dark cycle (lights on at 7.30
a.m, lights off from 7.30 p.m.) at an ambient temperature
of 24 ± 2 °C. Animals had free access to pelleted food
(Lipton India, Ltd) and water ad-libitum. All experiments
were performed according to the regulations and with
prior approval from Institute Animal Ethics Committee
(Reg. no. MMCP/IAEC/11/22).
Preparation of Spirulina fusiform
The spirulina powder (50 gm) was soaked in 1 L of
ultra-pure water and shaken continuously for 24 h at
room temperature. The mixture was then centrifuged at
5,000 rpm for 10 min (4 °C) and the supernatant was
filtered (Whatmann No. 1) to remove the cell debris.
The sample was then freeze-dried and the dried extract
was stored at 4 °C before use for the experiments.
Freeze-dried extract was suspended in vehicle (olive oil)
and was given to each rat by oral gavage daily, for 30 days
prior to lessioning. The extract was administered continu-
ously for 14 more days after conducted the surgery at the
same day with same dose.
Experimental design
6-OHDA-induced Parkinsonism
Animals were divided into eight groups. Each group
consisted of 14 animals
Group 1: Vehicle treated sham operated control (NS)
Group 2: Spirulina fusiform (500 mg/kg bodyweight/
day per oral) treated sham operated group (SS)
Group 3: Spirulina fusiform (500 mg/kg bodyweight/
twice a day per oral) treated sham operated group
(STS)
Group 4: Vehicle treated lesioned control—lesions
induced using 2 μL of 6-OHDA in ascorbic acid-saline
(LPC)
Group 5: Amantadine 20 mg/kg bodyweight treated
lesioned group (LA)
Group 6: Spirulina fusiform (500 mg/kg bodyweight/
day per oral) treated lesioned group (LS)
Group 7: Spirulina fusiform (500 mg/kg bodyweight/
twice a day per oral) treated lesioned group (LST)
Group 8: Spirulina fusiform (500 mg/kg bodyweight/
day per oral) + Amantadine 20 mg/kg orally treated
lesioned group (LSA)
Experimental Parkinsonism
Pretreatment with spirulina for continuously 30 days,
thirty minutes prior to surgery on day 31, rats received
i.p. 15 mg/kg of desipramine hydrochloride in order to
inhibit 6-OHDA-induced degeneration of noradrenergic
pathways [21]. Then, rats were lightly anaesthetized
with sodium pentobarbitone (45 mg/kg bodyweight, i.p)
and were placed in a stereotaxic apparatus. A stainless
steel needle (0.28 mm o.d) was inserted unilaterally
through a small hole in the skull and the needle tip was
placed into the dorsal striatum. The stereotaxic adjusted
according to the atlas of paxinos and Watson (1986) and
was follows as: A/P = −2.8 mm, L = +1.8 mm, D/V =
−8.6 mm [22]. Before surgery, freshly prepared solution of
6 −hydroxydopamine (6-OHDA) hydrochloride at a dose
of 10 μg dissolved in a 4 μl of sterile 0.9 % NaCl supple-
mented with 0.05 % ascorbic acid and was slowly infused
into the dorsal striatum at a flow rate of 0.5 μl/min using a
10-μl Hamilton syringe. After entire administered of 6-
OHDA, the cannula was left in place for further 5 mins
for complete diffusion of the toxin and then was slowly
retracted. Sham-operated rats were also treated in the
same manner, but received equivalent volumes of vehicle
instead of 6-OHDA hydrochloride.
Post-operative care
The effect of anesthesia was recovered by approxi-
mately 4–5 h. The rats were kept in a well-ventilated
room at 25 ± 3 °C in individual cages, till they gained
full consciousness and then were housed together in a
group of four animals per cage. Food and water was
kept inside the cages for the first week so that animals
could easily access it without any physical trauma due
to overhead injury.
Behavioral parameters
All behavioral analysis was performed by an observer
blinded to the group. Different tests were performed at
different time points after lesion over a period of
3 weeks.
Amphetamine-induced rotations
Amphetamine-induced rotations [23] were performed
on 37th day after administering 6-OHDA injection to
evaluate the extent of dopaminergic lesion. Rats were re-
ceived d-amphetamine sulfate (5.0 mg/kg i.p) and were
placed in rotometer bowls. They were allowed to habitu-
ate in their environment for 10 min before turns circling
in ipsiversive directions to the lesion and were recorded
continuously for 90 min. Results were expressed in ipsi-
lateral net turns/5 min.
Apomorphine-induced rotations
Apomorphine-induced rotations [23] were performed on
44th day at post-lesion. Apomorphine was injected s.c at
a dose of 0.5 mg/kg and rotations were monitored using
the same experimental setup as for amphetamine-
induced rotations. Results were expressed as contralat-
eral net turns/5 min [5].
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Spontaneous motor test
Locomotor activity
On 44th day, all the rats were tested for locomotor ac-
tivity in animal activity chamber [5]. The rats were
placed in the chamber individually and its locomotor
activity was monitored visually. The activity chamber
was furnished with black paper for easily assessing the
different parameters include locomotion, rest, rearing,
stereo events (number), rotations (clockwise), rotations
(anti clockwise) and distance travelled (cm). The activity
chamber was swabbed with 10 % alcohol at every time to
avoid the interference due to rat odors.
Rota rod (muscular coordination)
The muscular coordination was determined at 48th day
using digital rota rod apparatus. It consists of rotating
rod having 75 mm diameter and were divided into four
parts by compartmentalization to permit the testing for
individual rats at a same time [5]. The apparatus auto-
matically records the time in seconds when the rats fall
from the rotating shaft. The speed was set at 10 r.p.m
and cut of time was 180 s.
Biochemical studies
Tissue preparation for antioxidant assays
On 49th day, six rats were sacrificed from each group
and their brains were isolated quickly for harvesting
striatum and substantia nigra by cutting acrononal sec-
tion of 1.0 mm thickness using rat brain matrix in the
light of rat brain atlas [22]. Substantia nigra was used
for the estimation of thiobarbituric reactive substances
(TBARS) and reduced glutathione. Striatum was used
for dopamine levels.
Assay for thiobarbituric reactive substances, a marker of
lipid peroxidation
Estimation of lipid peroxidation was investigated by
Utley method [24]. About, 0.2 mL of post-mitochondrial
supernant liquid was pipetted in an eppendorf tube and
incubated at 37 ± 1 °C in a metabolic water bath shaker
for 60 min at 120 strokes up and down. Another 0.2 mL
was also pipetted in an eppendorf tube and placed at
0 °C for incubation. After 1 h of incubation, 0.4 mL of
5 % trichloro acetic acid and 0.4 mL of 0.67 % thiobar-
bituric acid were added in both the samples (i.e. 0 °C
and 37 °C). The reaction mixture was then transferred
from the vial to the tube and centrifuged at 1125 g for
15 min. The supernatant was transferred to another
tube and placed in a boiling water bath for 10 min.
Thereafter, the test tubes were cooled and the absorbance
was measured at 535 nm. The rate of lipid peroxidation
was expressed as nmol of TBARS reactive substance
formed/(h mg protein).
Assay for reduced glutathione content
Reduced glutathione was determined by the method of
Jollow, 1974 [25]. About 0.2 mL of post-mitochondrial
supernant liquid (10 %w/v) was precipitated with
0.2 mL of sulfosalicylic acid (4 %). The sample were kept
at 4 °C for at least 1 h and then subjected to centrifuga-
tion at 1200 g for 15 min at 4 °C. The total volume
(2 mL) of assay mixture contained 0.1 mL of filtered ali-
quot sample (10 %w/v), 1.7 mL of phosphate buffer
(0.1 M, pH 7.4) and 0.2 mL of 5-thio-2-nitrobenzoic acid
(4 mg/1 mL of phosphate buffer, 0.1 M, pH 7.4). After
yellow color developed, it was measured immediately at
412 nm.
Estimation of dopamine levels
Isolated dorsal striatum were weighed, frozen immedi-
ately in liquid nitrogen and stored at −70 °C until the
sample preparation. After thawing, tissue samples were
homogenized (1:10 w/v) in 0.1 M perchloric acid with
ultrasonic disintegrator. The homogenates were centri-
fuged for 15 mins at 15000 g at 4 °C, supernatants were
filtered and diluted (1:1) with 0.1 M perchloric acid.
Dopamine content in tissue homogenates of striatum
were determined by High-performance Liquid Chroma-
tography (HPLC) with subsequent electrochemical detec-
tion method [26–28] for separation and quantification.
The column was maintained at 35 °C. The mobile phase
consisted of 0.1 M potassium phosphate (pH 4.0), 10 %
methanol, and 1.0 mM heptanes sulfonic acid. Samples
were separated on an ODS-C18 column using a flow rate
of 1.0 mL/min. The concentrations of DA were calculated
using a standard curve generated by determining ratio
between known amounts of the amine and a constant
amount of internal standard and represented as ng/mg
of tissue.
Statistical analysis
The data were expressed as mean ± Standard deviation.
The statistical significances between means were ana-
lyzed using One-way analysis of variance (ANOVA)
followed by Tukey’s multiple range test. A p < 0.05 was
considered as statistical significant. Multivariate analysis
was done with post hoc bonferri test with SPSS Inc 16.0
software.
Results
Effect of Parkinsonism on behavior activity and its
restoration by Spirulina fusiformis
After post lesion, at 37th day, ipsilateral body rotations
were increased by 70.62 % with amphetamine and
80.62 % contra lateral body rotations were produced by
apomorphine on 44th day in the lesioned positive control
group (Fig. 1) when compared with normal saline sham
operated group. Thirty days prior and 14 days after the
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administration of 6-OHDA, twice daily dose of spirulina
treated lesioned group showed a good statistically signifi-
cant (p < 0.001) reduction in ispilateral circling behavior
by 34.26 and 52 % were decreased in contra lateral body
rotations. Overall, on 37th day, spirulina treated lesioned
groups and in combination of spirulina with amantadine
treated lesioned group showed a statistically significant
decline in number of rotations as per this order
(LSA>LA>LST>LS) and on 44th day, the effect was
shown like this LSA>LA = LST>LS.
A positive statistical (p < 0.0001) significantly interaction
was found in each group between behavior-behavior inter-
action (Additional file 1: Table S1) after induced by am-
phetamine and apomorphine. With post hoc analysis,
among all groups, a positive lesioned control group
(Group 4; Additional file 1: Table S1) showed a statistically
significant (p < 0.0001) difference in their results when
compared to all groups.
In activity chamber, lesioned positive control group
showed a significantly declined in percentage (73.81 %)
of locomotion activity when compared with normal
saline sham operated group (Fig. 2). A dose dependent
effect was shown by daily administration of single dose
of spirulina (71.6 %) and twice dose of spirulina (80.6 %)
treated lesioned group demonstrated a significant im-
provement in their body movements and extremely
highly statistical (p < 0.0001) significant difference in
their results on 44th day. A high percentage (83.4 %) of
locomotors activity was obtained after treatment with
spirulina plus amantadine treated lesioned group dem-
onstrated a highly statistically significant (p < 0.0001)
difference as mentioned in body movement and rest
activity.
Among all lesioned drug treated groups (Fig. 3), spiru-
lina administered twice daily and spirulina with amanta-
dine showed almost 33 and 55 % improvement in the
path covered by rats and showed statistically (p < 0.001)
significant difference when compared with lesioned posi-
tive control group declined in path covered (68.78 %).
Similar results in case of stereotype events (Fig. 4), treat-
ment of spirulina with amantadine combination exhib-
ited statistically (p < 0.001) significant enhancement
(78.58 %) when compared with lesioned positive control
group (↓76.68 %). Both spirulina treated lesioned groups
showed a dose dependent effect statistically (Spirulina
500 mg/kg once daily 24 %, p < 0.01; spirulina 500 mg/kg
twice daily 48.4 %, p < 0.001).
Tremendous effect (Fig. 5) was shown by spirulina
(500 mg/kg) twice daily revealed three fold improvement
(59.67 %) in rearing behavior in comparison with single
dose of spirulina (19.81 %). Spirulina with amantadine
treated lesioned group developed a 75.96 %, a highly
statistically significant (p < 0.001) difference. In muscle
coordination (Fig. 6), same enhancement (73.51 %) was
shown in combination of spirulina with amantadine
treated lesioned group than individual drug treatments
[Spirulina alone treated lesioned group (27.50 %) and
amantadine treated lesioned group (31.78 %)] after
Fig 1 The effect of treatment on body rotations. Each bar represents the mean ± standard deviation of six animals and the experiment were
repeated twice. ap < 0.001 vs. Saline sham operated, *p < 0.05,**p < 0.01,***p < 0.001 VS Lesioned positive control operated
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compared with lesioned positive control group by
69.98 % declined in muscle movements.
Overall in all behavior activities, spirulina (500 mg/kg,
twice daily) and spirulina plus amantadine treated
lesioned group confirmed a statistical significantly im-
provement in the prevention of Parkinsonism behavior.
However, no significant effects were shown in any
behavior activity in spirulina treated sham operated
groups when compared with normal saline sham oper-
ated group.
Effect of Parkinsonism on the content of thiobarbituric
acid reactive substances and reduced glutathione and
their protection by spirulina
The level of TBARS in substantia nigra was elevated
(70.59 %) significantly (p < 0.001) in the lesioned positive
control group when compared with normal saline sham
operated group (Fig. 7). A statistically significant reduc-
tion was obtained after chronic administration of spiru-
lina with amantadine treated lesioned group (73.81 %)
when compared with lesioned positive control group
Fig. 3 The effect of treatment on body path traveled. Each bar represents the mean ± standard deviation of six animals and the experiments
were repeated twice. ap < 0.001 vs Saline sham operated, *p < 0.05,**p < 0.01,***p < 0.001 VS Lesioned positive control operated
Fig. 2 The effect of treatments on body locomotion & rest. Each bar represents the mean ± standard deviation of six animals and the experiments
were repeated twice. ap < 0.001 vs Saline sham operated, *p < 0.05,**p < 0.01,***p < 0.001 VS Lesioned positive control operated
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whereas spirulina (twice daily) treated lesioned group
showed only 21.10 % and amantadine alone treated
lesioned group exhibited 30.3 %.
Similarly, the content of glutathione (Fig. 8) in substan-
tia nigra was significantly (p < 0.01) depleted (63.14 %) in
lesioned positive control group when compared with
normal saline sham operated group. In spirulina with
amantadine received lesioned group, the glutathione
level was restored extremely statistical significant (p <
0.001) than spirulina treated lesioned groups. Same in case
of dopamine level (Additional file 2: Table S2) showed
highly statistical significant increased (p < 0.001). Overall,
pretreatment of spirulina with amantadine treated le-
sioned group showed a highly statistical significant effects
in all behavior parameters when compared with lesioned
positive control group.
Discussion
Unilateral 6-OHDA-lesioned rats are widely used as a
model for Parkinson’s diseases (PD) for the molecular
mechanistic study approach involved in neuronal
dopaminergic degeneration [29]. Despite an extensive
Fig. 4 The effect of treatment on stereotype. Each bar represents the mean ± standard deviation of six animals and the experiments were
repeated twice. ap < 0.001 vs Saline sham operated, *p < 0.05,**p < 0.01,***p < 0.001 VS Lesioned positive control operated
Fig. 5 The effect of treatment on rearing. Each bar represents the mean ± standard deviation of six animals and the experiments were repeated
twice. ap < 0.001 vs Saline sham operated, *p < 0.05,**p < 0.01,*** < 0.001 VS Lesioned positive control operated
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investigation conducted by many researchers, our aim
was to find out the effective and easily approach for
the treatment of this disorder. A pre and post treat-
ment of spirulina extract alone and in combination of
spirulina with amantadine treated lesioned group
showed a protective brain response after lesioned and
demonstrated a same type of effect in rat behavior
which was supported by other studies also [30, 31].
The results of the present study indicated that both pre
and post treatment showed a significant extremely
effective positive response against 6-OHDA induced
abnormal behavior and increased oxidant enzymes in
rats. Different behavior activities like body movements,
locomotor activity, distance travelled, stereotype events,
rearing behavior and muscle coordination (Figs. 1, 2, 3, 4,
5, 6) produced a drastically statistical (p < 0.001) signifi-
cant improvement after treated with spirulina alone and in
combination with amantadine. By factorial design (multi-
variate analysis) at all levels (Additional file 1: Table S1),
Overall, there were statistically significant difference
(p < 0.0001) between groups and within subjects when
compared to other positive lesioned treated groups.
Fig. 6 The effect of treatment on muscle coordination. Each bar represents the mean ± standard deviation of six animals and the experiment
were repeated twice. ap < 0.001 vs. Saline sham operated, *p < 0.05,**p < 0.01,***p < 0.001 VS Lesioned positive control operated
Fig. 7 The effect of treatments on thiobarbituric acid reactive substrates. Each bar represents the mean ± standard deviation of six animals and
the experiments were repeated twice. ap < 0.001 vs Saline sham operated, *p < 0.05,**p < 0.01,***p < 0.001 VS Lesioned positive control operated
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From our results, it also showed that spirulina
(500 mg/kg) potentiates the action of amantadine
when treated in combination in 6-OHDA induced
damage in rat brain. Similarly, in case of anti-oxidant
assays and dopamine level, a combined treatment
showed best protective results as a statistical highly
significant improvement and restoration of striatal
dopamine levels (Additional file 2: Table S2). The content
of thiobarbituric acid (Fig. 7) was reduced and glutathione
level was increased (Fig. 8).
Various studies have been reported to show contra-
dictory results depending upon various factors like use
of different methodologies, strains, geographical regions,
environmental factor, indicators of oxidative stress and
species of animals. A study conducted by one of the re-
searcher showed that oxidative stress was increased in
younger rats rather in all age groups of rats after induced
by 6-OHDA due to inability of detoxify free radicals in
younger animals than aging animals [32]. Vice versa re-
sults were reported through other studies [33]. Another
researcher conducted a time course study suggested an
alteration of oxidative stress in rats [34, 35].
Brains of PD patient showed low levels of endogenous
antioxidants [36]. Antioxidants might be one of the ideal
agents to prevent free radical-mediated tissue destruc-
tion and inhibit some of the early degenerative events.
Natural and endogenous antioxidants such as polyphe-
nols, coenzyme Q10, and vitamins A, C, and E have
been proposed as therapeutic agents for preventing and
delaying the development of PD [37]. Various epidemio-
logical studies demonstrated a regular consumption of a
mediterranean diet (high levels of vitamin C, vitamin E,
flavonoids, and carotenoids) can lower the risk of neuro-
logical disorders [38–40]. In animal experimental model,
chronic usage of blueberry, spinach, or spirulina-enriched
diets showed a declines in age-related disorders and re-
stores the dopamine levels in the striatum [41–46].
In our study, at 48th day, spirulina extract alone
treated lesioned group and in combination with amanta-
dine showed a marvelous antioxidant activity through
various antioxidant assays however, dopamine level
could not reach near normal level, in spirulina alone
(500 mg/kg once daily and twice daily) treated lesioned
group when compared with amantadine combination. A
similar study was supported to show anti-inflammatory
and anti-oxidant properties with blueberry and spirulina
enriched diet, improved a recovery at the nerve terminal
rather than cellular level [17]. After 1 month the recov-
ery of striatal TH-positive nerve fibers were increased
while a loss of dopamine neurons was slightly improved.
This type of effect is may be due to sprouting from
non-injured dopamine neurons rather from regenerat-
ing rescued dopamine neurons or up regulation of lost
TH synthesis which was reported by Stromberg [17].
Furthermore, it was also reported that, spirulina blocked
the cyclooxygenase pathway which showed significant
regeneration of TH-positive nerve fibers [47]. The
probable mechanism responsible for this effect is may
be due to the presence of phycocyanin, phycocyanobilin
and beta carotene, as these are reported to have strong
anticyclooxygenase-2 and antioxidant activities [10, 48].
Another study also reported that spirulina supplementation
Fig. 8 The effect of treatments on reduced glutathione levels. Each bar represents the mean ± standard deviation of six animals and the
experiments were repeated twice. bp < 0.01 vs Saline sham operated, *p < 0.05,**p < 0.01,***p < 0.001 VS Lesioned positive control operated
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decreases the lipid peroxidation and increased the levels of
reduced glutathione in humans [49]. Extracts of spirulina
have antioxidant activity both in vivo and in vitro. Similar
results were found with spirulina treated on rats against the
neuronal loss induced by α-synuclein [19].
Another potential constituent present in spirulina is
gamma-linolenic acid which decreased the lipid peroxi-
dation [50]. Indeed, it has been found that an increased
ratio of gamma-linolenic acid to arachidonic acid is
capable of attenuating the biosynthesis of arachidonic
acid metabolites (i.e., prostaglandins, leukotrienes, and
platelet-activating factor) and exerts an anti-inflammatory
effect [50]. Decreased inflammation via this route might
have decreased the production of superoxide, hydrogen
peroxide, and hypochlorous acid by the activated neutro-
phils leading to less lipid peroxidation after spirulina sup-
plementation. There are many active components present
in spirulina which may show an insight stories about ex-
cellent protectively in various disorders. Many of spirulina
constituents may interact with microglia to reduce micro-
glia activation. The reason for this effect is still unknown.
Excellent synergistic neuroprotective effect was shown by
spirulina with amantadine combination and neuroprotec-
tive effect of amantadine is may be due to formation of
conjugates/derivatives which was also reported in earlier
studies [51, 52]. However, pharmacokinetic interaction
between spirulina and amantadine will provide more
insight into this beneficial interaction.
Although disease-modifying therapies have not yet
found their way to clinical practice, a substantial num-
ber of compounds have been identified as neuroprotec-
tive in preclinical studies. Since most physicians rarely
access or appraise scientific evidence directly from re-
search results, most neurologists have overlooked preclin-
ical improvements, resulting in lowered expectations and
misplaced doubts about neuroprotection. Spirulina
supplementation has been shown to offer significant
protection against a number of environmental toxi-
cants, chemical or drug-induced oxidative stress and
inflammation.
Many patients on amantadine therapy are mandatory
to take antioxidants simultaneously. Hence, the results
of this study have direct relevance clinically. Though,
the results of this study can be extrapolated to benefi-
cial effects of combination of amantadine with other
antioxidants, we recommend that such combinations
should only be used only after thorough pharmacoki-
netic and pharmacodynamic interaction studies. There
are multi path physiology are involved which can lead
to Parkinson’s disease such as cyclooxygenase pathway,
TNF-α and cholinergic action. It is very difficult to
predict the anti Parkinsonism effect at pharmacological
level unless until the molecular levels studies are
conducted.
Conclusion
Finally, it is concluded that, pretreatment with spirulina
showing anti-parkinsonism effect on behavior and anti-
oxidant parameters on 6-OHDA induced dopaminergic
damage rats. Spirulina also potentiates the anti-
parkinsonian effect of amantadine when administered in
combination. The neurodegenerative disorder is well
known in aging related problems but now a day’s many of
the researchers reported that chronic condition of type 2
diabetes mellitus induces neurodegenerative disorders like
Parkinsonism and Alzheimer diseases. So, this study is
preliminary study on Parkinsonism rat model and spiru-
lina is an added advantage to Parkinsonism patients when
given with amantadine in chronic type 2 diabetes induced
neurodegenerative disorder especially in Parkinsonism
disorder in future studies.
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